BioCentury
ARTICLE | Clinical News

Palmaz-Schatz: IsoStent will start a Phase I trial in the next month in 30 patients.

August 19, 1996 7:00 AM UTC

IsoStent Inc., San Carlos, Calif. Product: Palmaz-Schatz stent made radioactive Indication: Prevent restenosis after coronary artery treatment Status: IsoStent will start a Phase I trial in the next ...